↓ Skip to main content

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

Overview of attention for article published in Clinical and Molecular Hepatology, March 2013
Altmetric Badge

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience
Published in
Clinical and Molecular Hepatology, March 2013
DOI 10.3350/cmh.2013.19.1.51
Pubmed ID
Authors

Myung Jin Oh, Heon Ju Lee

Abstract

The widespread use of cytotoxic chemotherapy and immunosuppressants has resulted in reactivation of hepatitis B virus (HBV) recently becoming an issue. Although rituximab (an anti-CD20 monoclonal antibody) has revolutionized the treatment of lymphoma, recent reports have suggested that rituximab therapy increases the risk of viral-mediated complications, and particularly HBV reactivation. This study analyzed real clinical practice data for rituximab-related HBV reactivation.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 19%
Other 2 7%
Student > Bachelor 2 7%
Student > Doctoral Student 2 7%
Researcher 2 7%
Other 7 26%
Unknown 7 26%
Readers by discipline Count As %
Medicine and Dentistry 11 41%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Biochemistry, Genetics and Molecular Biology 1 4%
Nursing and Health Professions 1 4%
Immunology and Microbiology 1 4%
Other 3 11%
Unknown 8 30%